Displaying items by tag: Perrigo Co plc
Stock prices of West Michigan’s publicly traded companies tumbled on Friday as Wall Street succumbed to the uncertainty caused by the U.K.’s decision to exit the European Union.
Here is the MiBiz Growth Report for June 27, 2016.
• M&A: German company Kion Group AG, an industrial truck, material handling and logistics automation equipment manufacturer, plans to acquire Dematic Corp. for approximately $2.1 billion in what executives described as a “landmark” transaction. The deal values the logistics and automation firm, whose North American operations are based in Grand Rapids, at an enterprise value of $3.25 billion, according to a joint statement. Dematic generated $1.8 billion in revenues and $166 million in adjusted earnings before interest and taxes during the calendar year 2015. Kion Group will acquire Dematic from funds managed by New York City private equity firm AEA Investors LP and the Ontario Teachers Pension Plan. The deal, which is expected to close in the fourth quarter pending regulatory approval, also carves out “certain liabilities,” according to a statement.
Perrigo Co. plc will sell off its vitamins, minerals and supplements business to International Vitamin Corp. of Freehold, N.J.
A trademark lawsuit involving two drug companies in West Michigan has been settled out of court, according to documents filed yesterday in federal court.
Responsibly managing corporate finances increasingly requires the best financial executives to expand their scope by branching out into other roles. That was one key message this year’s winners in the MiBiz CFO of the Year Awards shared during a best practices panel discussion this week.
Problems with operations in Europe drove Perrigo Co. plc to a loss in the first quarter amid higher sales.
ALLEGAN — John Hendrickson assumed command at Perrigo Co. plc as the company faces problems in Europe that will cut into 2016 earnings.
Perrigo Co. plc today quickly named John Hendrickson as chief executive officer following the resignation of Chairman and CEO Joe Papa.
Perrigo Co. plc is saying little about a report that Chairman and CEO Joe Papa may leave to become chief executive at Valeant Pharmaceuticals International Inc.